Protalix BioTherapeutics
PLX
#8420
Rank
A$0.28 B
Marketcap
$3.83
Share price
0.42%
Change (1 day)
69.45%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -A$11.83 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are A$45.66 Million. In 2023 the company made an earning of A$18.9 Million, an increase over its 2022 earnings that were of -A$19.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$11.83 Million-162.52%
2023 A$18.9 M-199.05%
2022 -A$19.09 Million-40.38%
2021 -A$32.02 Million-732.31%
2020 A$5.06 M-130.53%
2019 -A$16.59 Million189.85%
2018 -A$5.73 Million-95.29%
2017 -A$0.13 Billion308.12%
2016 -A$29.78 Million-32.37%
2015 -A$44.03 Million10.11%
2014 -A$39.99 Million-7.59%
2013 -A$43.27 Million
2011 -A$50.11 Million-19.39%
2010 -A$62.16 Million20.87%
2009 -A$51.43 Million32.26%
2008 -A$38.89 Million-5.46%
2007 -A$41.13 Million
2004 -A$0.27 Million12.35%
2003 -A$0.24 Million-11.1%
2002 -A$0.27 Million-57.03%
2001 -A$0.63 Million1.03%
2000 -A$0.62 Million-53.22%
1999 -A$1.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.11 Billion 781.03%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.05 B-8,564.81%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.16 B-89,594.72%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.67 B-5,513.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel